Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk’s chief of staffs to leave

Company reduces number of executives from seven to six
Lise Kingo, Novo Nordisk

Novo Nordisk has decided to reduce the number of its executives from seven to six resulting in the departure of its chief of staffs Lise Kingo.

Kingo's responsibilities will be split among the remaining executives, including Lars Fruergaard Jørgensen, Jakob Riis and CEO Lars Rebien Sørensen.

Sørensen said: "I would like to thank Lise for her many contributions to Novo Nordisk during her impressive career in the company. Of special note is her leadership in driving the company's strategy within sustainable development, corporate branding and public affairs, which has earned Novo Nordisk recognition as a respected global business.”

Kingo joined Novo in 1988 and worked her way up the ranks, being appointed senior VP in 1999 and then as executive VP and chief of staffs in 2002. Her other roles include chair of the board of Steno Diabetes Center and member of the board of Grieg Star Group.

27th November 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics